Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy
- 4 December 2019
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 156 (1) , 100-106
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute Cancer Center (P30CA225520)
This publication has 11 references indexed in Scilit:
- Definitive local therapy is associated with improved overall survival in metastatic cervical cancerPractical Radiation Oncology, 2018
- Association of Definitive Pelvic Radiation Therapy With Survival Among Patients With Newly Diagnosed Metastatic Cervical CancerJAMA Oncology, 2018
- Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancerGynecologic Oncology, 2018
- Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)The Lancet, 2017
- Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and TreatmentGynecologic and Obstetric Investigation, 2017
- Effect of Hydronephrosis on Survival in Advanced Stage Cervical CancerAsian Pacific Journal of Cancer Prevention, 2015
- Curative Chemoradiotherapy in Patients With Stage IVB Cervical Cancer Presenting With Paraortic and Left Supraclavicular Lymph Node MetastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Quality of life and survival in advanced cervical cancer: A Gynecologic Oncology Group studyGynecologic Oncology, 2012
- Hydronephrosis as a Prognostic Indicator of Survival in Advanced Cervix CancerInternational Journal of Gynecological Cancer, 2011
- Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapyRadiation Medicine, 2006